首页> 美国卫生研究院文献>Springer Open Choice >The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
【2h】

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

机译:阿尔茨海默氏症的β-分泌酶BACE1定位于正常的突触前末端和淀粉样斑块周围的营养不良的突触前末端

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

β-Site amyloid precursor protein (APP) cleaving enzyme-1 (BACE1) is the β-secretase that initiates Aβ production in Alzheimer’s disease (AD). BACE1 levels are increased in AD, which could contribute to pathogenesis, yet the mechanism of BACE1 elevation is unclear. Furthermore, the normal function of BACE1 is poorly understood. We localized BACE1 in the brain at both the light and electron microscopic levels to gain insight into normal and pathophysiologic roles of BACE1 in health and AD, respectively. Our findings provide the first ultrastructural evidence that BACE1 localizes to vesicles (likely endosomes) in normal hippocampal mossy fiber terminals of both non-transgenic and APP transgenic (5XFAD) mouse brains. In some instances, BACE1-positive vesicles were located near active zones, implying a function for BACE1 at the synapse. In addition, BACE1 accumulated in swollen dystrophic autophagosome-poor presynaptic terminals surrounding amyloid plaques in 5XFAD cortex and hippocampus. Importantly, accumulations of BACE1 and APP co-localized in presynaptic dystrophies, implying increased BACE1 processing of APP in peri-plaque regions. In primary cortical neuron cultures, treatment with the lysosomal protease inhibitor leupeptin caused BACE1 levels to increase; however, exposure of neurons to the autophagy inducer trehalose did not reduce BACE1 levels. This suggests that BACE1 is degraded by lysosomes but not by autophagy. Our results imply that BACE1 elevation in AD could be linked to decreased lysosomal degradation of BACE1 within dystrophic presynaptic terminals. Elevated BACE1 and APP levels in plaque-associated presynaptic dystrophies could increase local peri-plaque Aβ generation and accelerate amyloid plaque growth in AD.Electronic supplementary materialThe online version of this article (doi:10.1007/s00401-013-1152-3) contains supplementary material, which is available to authorized users.
机译:β-位淀粉样蛋白前体蛋白(APP)裂解酶1(BACE1)是在阿尔茨海默病(AD)中引发Aβ产生的β-分泌酶。 AD中BACE1的水平升高,可能与发病有关,但BACE1升高的机制尚不清楚。此外,人们对BACE1的正常功能了解甚少。我们在光学和电子显微镜下将BACE1定位在大脑中,以深入了解BACE1在健康和AD中的正常和病理生理作用。我们的发现提供了第一个超微结构证据,即BACE1定位于非转基因和APP转基因(5XFAD)小鼠大脑正常海马苔藓纤维末端的囊泡(可能是内体)。在某些情况下,BACE1阳性小泡位于活动区附近,这意味着BACE1在突触中具有功能。此外,BACE1积累在5XFAD皮质和海马中淀粉样蛋白斑块周围营养不良的自噬体的营养不良的末端。重要的是,BACE1和APP的积累在突触前营养不良中共定位,这意味着斑块周围区域APP的BACE1处理增加。在原代皮层神经元培养物中,溶酶体蛋白酶抑制剂leupeptin的治疗可导致BACE1水平升高。然而,神经元暴露于自噬诱导剂海藻糖并不能降低BACE1水平。这表明BACE1被溶酶体降解,但不被自噬降解。我们的结果表明,AD中BACE1升高可能与营养不良的突触前末端内BACE1的溶酶体降解降低有关。斑块相关的突触前营养不良中BACE1和APP水平升高可能会增加AD中斑块周围Aβ的产生并加速淀粉样斑块的生长。电子补充材料本文的在线版本(doi:10.1007 / s00401-013-1152-3)包含补充资料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号